Page last updated: 2024-08-21

dexamethasone 21-phosphate and Macular Degeneration

dexamethasone 21-phosphate has been researched along with Macular Degeneration in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guthrie, MJ; Kang-Mieler, JJ; Mieler, WF; Osswald, CR; Valio, NL1
Deligiannis, I; Echiadis, G; Giannikakis, S; Kavalarakis, E; Papaefthymiou, I; Pervena, A; Vakalis, N1

Trials

1 trial(s) available for dexamethasone 21-phosphate and Macular Degeneration

ArticleYear
Intravitreal combination of dexamethasone sodium phosphate and bevacizumab in the treatment of exudative AMD.
    Scientific reports, 2015, Feb-27, Volume: 5

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Drug Combinations; Female; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Pilot Projects; Retina; Treatment Outcome

2015

Other Studies

1 other study(ies) available for dexamethasone 21-phosphate and Macular Degeneration

ArticleYear
Objective area measurement technique for choroidal neovascularization from fluorescein angiography.
    Microvascular research, 2014, Volume: 91

    Topics: Animals; Bruch Membrane; Choroidal Neovascularization; Dexamethasone; Fluorescein; Fluorescein Angiography; Humans; Hydrogels; Image Processing, Computer-Assisted; Intravitreal Injections; Lasers; Macular Degeneration; Male; Nanospheres; Rats; Rats, Long-Evans; Triamcinolone Acetonide

2014